Procoagulant factors and the risk of myocardial infarction in young women

被引:52
作者
Tanis, Bea
Algra, Ale
van der Graaf, Yolanda
Helmerhorst, Frans
Rosendaal, Frits
机构
[1] Leiden Univ, Dept Clin Epidemiol, Med Ctr, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Dept Haematol, Med Ctr, NL-2300 RC Leiden, Netherlands
[3] Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[4] Univ Utrecht, Med Ctr, Dept Neurol, Utrecht, Netherlands
[5] Leiden Univ, Dept Gynaecol & Reprod Med, Med Ctr, NL-2300 RC Leiden, Netherlands
关键词
case-control study; coagulation factors; myocardial infarction; risk factor; women;
D O I
10.1111/j.1600-0609.2006.00656.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: We investigated whether elevated levels of factor VIII, IX and XI is associated with myocardial infarction (MI) in young women. In addition, we studied ABO blood group, von Willebrand factor (VWF) and C-reactive protein (CRP). Methods and results: We compared 200 women with MI before age 49 years with 626 controls from a population-based case-control study. Mean levels of factor VIII activity (VIII), von Willebrand factor antigen (VWF), factor IX activity (IX) were higher in patients (133, 134 and 132 IU/dL) than in controls (111, 107 and 120 IU/dL, respectively). Mean levels of factor XI (XI) were equal in patients (114 IU/dL) and controls (113 IU/dL). The odds ratio (OR) for MI for blood group non-O vs. O was 1.6 [95% confidence interval (CI) 1.1-2.3]. The OR adjusted for age, index year and area of residence for the highest quartile > 150 IU/dL of factor VIII was 2.7 (95% CI 1.6-4.6), of VWF 4.7 (95% CI 2.3-9.7), of factor IX 2.6 (95% CI 1.3-5.4) and of factor XI 0.9 (95% CI 0.5-1.4), all compared with the lowest quartile < 100 IU/dL. Conclusions: Non-O blood group, high VWF, factor VIII and factor IX levels are associated with an increased risk of MI in young women, while high factor XI levels are not.
引用
收藏
页码:67 / 73
页数:7
相关论文
共 46 条
[1]  
BALLEISEN L, 1985, THROMB HAEMOSTASIS, V54, P475
[2]  
Bouma BN, 1998, THROMB HAEMOSTASIS, V80, P24
[3]   Role of blood coagulation factor XI in downregulation of fibrinolysis [J].
Bouma, BN ;
Meijers, JCM .
CURRENT OPINION IN HEMATOLOGY, 2000, 7 (05) :266-272
[4]   BLEEDING-TIME, BLOOD-GROUPS AND VONWILLEBRAND-FACTOR [J].
CAEKEBEKEPEERLINCK, KMJ ;
KOSTER, T ;
BRIET, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1989, 73 (02) :217-220
[5]  
CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380
[6]   COMPARATIVE BEHAVIOR OF THE COMPONENTS OF THE FACTOR-VIII COMPLEX IN ACUTE MYOCARDIAL-INFARCTION [J].
CUCUIANU, MP ;
CRISTEA, A ;
ROMAN, S ;
RUS, H ;
MISSITS, I ;
PECHET, L .
THROMBOSIS RESEARCH, 1983, 30 (05) :487-497
[7]   THE COAGULATION CASCADE - INITIATION, MAINTENANCE, AND REGULATION [J].
DAVIE, EW ;
FUJIKAWA, K ;
KISIEL, W .
BIOCHEMISTRY, 1991, 30 (43) :10363-10370
[8]   C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men [J].
Doggen, CJM ;
Berckmans, RJ ;
Sturk, A ;
Cats, VM ;
Rosendaal, FR .
JOURNAL OF INTERNAL MEDICINE, 2000, 248 (05) :406-414
[9]   Prospective study of hemostatic factors and incidence of coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) Study [J].
Folsom, AR ;
Wu, KK ;
Rosamond, WD ;
Sharrett, AR ;
Chambless, LE .
CIRCULATION, 1997, 96 (04) :1102-1108
[10]  
GILL JC, 1987, BLOOD, V69, P1691